Superiority of PLK-2 as α-synuclein phosphorylating agent relies on unique specificity determinants

Biochemical and Biophysical Research Communications

Volumn 418, Issue 1, 2012, Pages 156-160

  Salvi, Mauro ^a   Trashi, Edlir ^a   Marin, Oriano ^a   Negro, Alessandro ^a   Sarno, Stefania ^a   Pinna, Lorenzo A ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

Synuclein; CK2; Parkinson's disease; PLK2; PLK3

Indexed keywords

ALANINE; ALPHA SYNUCLEIN; CASEIN KINASE II; COMPLEMENTARY DNA; GLUTAMINE; GLYCINE; POLO LIKE KINASE 2; SERINE;

AMINO ACID SUBSTITUTION; ARTICLE; CARBOXY TERMINAL SEQUENCE; CATALYST; ENZYME ANALYSIS; ENZYME PHOSPHORYLATION; ENZYME PURIFICATION; ENZYME SPECIFICITY; ENZYME STRUCTURE; HUMAN; IN VITRO STUDY; KINETICS; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ALPHA-SYNUCLEIN; CASEIN KINASE II; CATALYSIS; HUMANS; PEPTIDES; PHOSPHORYLATION; PROTEIN-SERINE-THREONINE KINASES; SERINE;

EID: 84856507495     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2011.12.152     Document Type: Article

References (26)

1. Fujiwara H., Hasegawa M., Dohmae N., Kawashima A., Masliah E., Goldberg M.S., Shen J., Takio K., Iwatsubo T. Alpha-Synuclein is phosphorylated in synucleinopathy lesions. Nat. Cell Biol. 2002, 4:60-64.
2. Okochi M., Walter J., Koyama A., Nakajo S., Baba M., Iwatsubo T., Meijer L., Kahle P.J., Haass C. Constitutive phosphorylation of the Parkinson's disease associated alpha-synuclein. J. Biol. Chem. 2000, 275:390-397.
3. Kahle P.J., Neumann M., Ozmen L., Muller V., Jacobsen H., Spooren W., Fuss B., Mallon B., Macklin W.B., Fujiwara H., Hasegawa M., Iwatsubo T., Kretzschmar H.A., Haass C. Hyperphosphorylation and insolubility of alpha-synuclein in transgenic mouse oligodendrocytes. EMBO Rep. 2002, 3:583-588.
4. Takahashi M., Kanuka H., Fujiwara H., Koyama A., Hasegawa M., Miura M., Iwatsubo T. Phosphorylation of alpha-synuclein characteristic of synucleinopathy lesions is recapitulated in alpha-synuclein transgenic Drosophila. Neurosci. Lett. 2003, 336:155-158.
5. Cavallarin N., Vicario M., Negro A. The role of phosphorylation in synucleinopathies: focus on Parkinson's disease. CNS Neurol. Disord. Drug Targets 2010, 9:471-481.
6. Anderson J.P., Walker D.E., Goldstein J.M., de Laat R., Banducci K., Caccavello R.J., Barbour R., Huang J., Kling K., Lee M., Diep L., Keim P.S., Shen X., Chataway T., Schlossmacher M.G., Seubert P., Schenk D., Sinha S., Gai W.P., Chilcote T.J. Phosphorylation of Ser-129 is the dominant pathological modification of alpha-synuclein in familial and sporadic Lewy body disease. J. Biol. Chem. 2006, 281:29739-29752.
7. Pronin A.N., Morris A.J., Surguchov A., Benovic J.L. Synucleins are a novel class of substrates for G protein-coupled receptor kinases. J. Biol. Chem. 2000, 275:26515-26522.
8. Ishii A., Nonaka T., Taniguchi S., Saito T., Arai T., Mann D., Iwatsubo T., Hisanaga S., Goedert M., Hasegawa M. Casein kinase 2 is the major enzyme in brain that phosphorylates Ser129 of human alpha-synuclein: Implication for alpha-synucleinopathies. FEBS Lett. 2007, 581:4711-4717.
9. Waxman E.A., Giasson B.I. Specificity and regulation of casein kinase-mediated phosphorylation of alpha-synuclein. J. Neuropathol. Exp. Neurol. 2008, 67:402-416.
10. Pinna L.A., Ruzzene M. How do protein kinases recognize their substrates?. Biochim. Biophys. Acta 1996, 1314:191-225.
11. Meggio F., Pinna L.A. One-thousand-and-one substrates of protein kinase CK2?. FASEB J. 2003, 17:349-368.
12. Negro A., Brunati A.M., Donella-Deana A., Massimino M.L., Pinna L.A. Multiple phosphorylation of alpha-synuclein by protein tyrosine kinase Syk prevents eosin-induced aggregation. FASEB J. 2002, 16:210-212.
13. Inglis K.J., Chereau D., Brigham E.F., Chiou S.S., Schöbel S., Frigon N.L., Yu M., Caccavello R.J., Nelson S., Motter R., Wright S., Chian D., Santiago P., Soriano F., Ramos C., Powell K., Goldstein J.M., Babcock M., Yednock T., Bard F., Basi G.S., Sham H., Chilcote T.J., McConlogue L., Griswold-Prenner I., Anderson J.P. Polo-like kinase 2 (PLK2) phosphorylates alpha-synuclein at serine 129 in central nervous system. J. Biol. Chem. 2009, 284:2598-2602.
14. Mbefo M.K., Paleologou K.E., Boucharaba A., Oueslati A., Schell H., Fournier M., Olschewski D., Yin G., Zweckstetter M., Masliah E., Kahle P.J., Hirling H., Lashuel H.A. Phosphorylation of synucleins by members of the Polo-like kinase family. J. Biol. Chem. 2010, 285:2807-2822.
15. Johnson E.F., Stewart K.D., Woods K.W., Giranda V.L., Luo Y. Pharmacological and functional comparison of the polo-like kinase family: insight into inhibitor and substrate specificity. Biochemistry 2007, 46:9551-9563.
16. Warnke S., Kemmler S., Hames R.S., Tsai H.L. HU. Hoffmann-Rohrer, A.M. Fry, I. Hoffmann, Polo-like kinase-2 is required for centriole duplication in mammalian cells. Curr. Biol. 2004, 14:1200-1207.
17. López-Sánchez I., Sanz-García M., Lazo P.A. Plk3 interacts with and specifically phosphorylates VRK1 in Ser342, a downstream target in a pathway that induces Golgi fragmentation. Mol. Cell Biol. 2009, 29:1189-1201.
18. Salvi M., Sarno S., Marin O., Meggio F., Itarte E., Pinna L.A. Discrimination between the activity of protein kinase CK2 holoenzyme and its catalytic subunits. FEBS Lett. 2006, 580:3948-3952.
19. Fields G.B., Noble R.L. Solid phase peptide synthesis utilizing 9- fluorenylmethoxycarbonyl amino acids. Int. J. Pept. Protein Res. 1990, 35:161-214.
20. Borghi R., Marchese R., Negro A., Marinelli L., Forloni G., Zaccheo D., Abbruzzese G., Tabaton M. Full length alpha-synuclein is present in cerebrospinal fluid from Parkinson's disease and normal subjects. Neurosci. Lett. 2000, 287:65-67.
21. Salvi M., Sarno S., Cesaro L., Nakamura H., Pinna L.A. Extraordinary pleiotropy of protein kinase CK2 revealed by web logo phosphoproteome analysis. Biochim. Biophys. Acta 2009, 1793:847-859.
22. Marin O., Meggio F., Pinna L.A. Design and synthesis of two new peptide substrates for the specific and sensitive monitoring of casein kinases-1 and -2. Biochem. Biophys. Res. Commun. 1994, 198:898-905.
23. Lasa-Benito M., Marin O., Meggio F., Pinna L.A. Golgi apparatus mammary gland casein kinase: monitoring by a specific peptide substrate and definition of specificity determinants. FEBS Lett. 1996, 382:149-152.
24. Ubersax J.A., Ferrell J.E. Mechanisms of specificity in protein phosphorylation. Nat. Rev. Mol. Cell. Biol. 2007, 8:530-541.
25. Bustos V.H., Ferrarese A., Venerando A., Marin O., Allende J.E., Pinna L.A. The first armadillo repeat is involved in the recognition and regulation of beta-catenin phosphorylation by protein kinase CK1. Proc. Natl. Acad. Sci. USA 2006, 103:19725-19730.
26. Venerando A., Marin O., Cozza G., Bustos V.H., Sarno S., Pinna L.A. Isoform specific phosphorylation of p53 by protein kinase CK1. Cell. Mol. Life Sci. 2010, 67:1105-1118.